← All candidates
6 insider filings on record.
19 filings on record.
OVIDOvid Therapeutics Inc.
NasdaqCM · Healthcare · $525.35M
$2.69
+2.28% · Sep 11
6 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 2 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$525.35M
Float
163.4M
84% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
331.9
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
3 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
1 more transaction on Pro →Context
Wall St
$5.47 avg target
+103.4% vs today · 9 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$0.12 act−$0.01
Q4 '25$0.06 act+$0.16
Q3 '25−$0.17 act−$0.02
Q2 '25−$0.06 act+$0.09
Coverage
We're Hopeful That Ovid Therapeutics (NASDAQ:OVID) Will Use Its Cash WiselySimply Wall St. · 05-14Here is Why Ovid Therapeutics (OVID) is One of the Best Fast Growing Penny StocksInsider Monkey · 05-10Ovid Therapeutics Q4 Earnings Call HighlightsMarketBeat · 03-18Here's Why Ovid Therapeutics Stock Popped Higher TodayMotley Fool · 03-18
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice